2026-01-20 - Analysis Report
**Meta Stock Report**
=====================

**Company Overview**
------------------

Meta is a technology company that specializes in social media and online advertising.

**Cumulative Return Comparison**
-------------------------------

| Ticker | Cumulative Return |
| --- | --- |
| META | 95.78% |
| VOO (S&P 500) | 93.30% |

The divergence is 2.48% (47.00% relative divergence).

**Alpha, Beta Analysis**
-----------------------

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -17.0% | 38.5% | -21.0% | 1.2 | 330.4B |
| 2017-2019 | 10.0% | 38.5% | -8.0% | 1.3 | 517.3B |
| 2018-2020 | 0.0% | 38.5% | -20.0% | 1.1 | 688.5B |
| 2019-2021 | 35.0% | 20.9% | -8.0% | 1.1 | 847.8B |
| 2020-2022 | -54.0% | 65.8% | -52.0% | 1.2 | 303.3B |
| 2021-2023 | 16.0% | 65.8% | 15.0% | 1.7 | 892.2B |
| 2022-2024 | 69.0% | 61.3% | 49.0% | 1.7 | 1475.8B |
| 2023-2025 | 132.0% | 27.0% | 70.0% | 1.5 | 1663.8B |

**Recent Stock Price Fluctuations**
---------------------------------

* Close: $620.25
* Last-market: -0.09%
* 5-day SMA: $625.93
* 20-day SMA: $650.62
* 60-day SMA: $650.13

The recent stock price fluctuations indicate a downward trend.

**RSI, PPO Index Indicators**
-----------------------------

| Indicator | Value |
| --- | --- |
| RSI | 29.01 |
| PPO | -0.73 |
| MRI | 0.80 |
| Expected Return | 10.40% |

The RSI and PPO indicators suggest a bearish trend, while the MRI and Expected Return indicate a medium-risk investment.

**Delta_Previous_Relative_Divergence**
-----------------------------------

Recent (20 days) relative divergence change: -5.80 (-)
7-day Rank change: 14 (+)
7-day Dynamic Expected Return change: 1.80 (+)

The recent relative divergence change indicates worsening performance.

**Recent News & Significant Events**
-----------------------------------

* [2026-01-16] 3 Risks That Every Meta Stock Investor Should Know - Forbes
* [2026-01-18] Meta (META)’s Shares Are Down Because It’s A Lone Wolf, Says Jim Cramer - Yahoo Finance
* [2026-01-17] Is Meta Stock a Buy Going Into 2026? - The Motley Fool
* [2026-01-18] Meta stock holds near $620 as a holiday week starts and investors eye Powell pay filing, teen-safety lawsuits - TechStock²
* [2026-01-17] Meta stock: $60 million pay package detail drops as investors brace for earnings and AI spending test - TechStock²
* [2026-01-16] Meta Stock: No One Is More All-In on AI Than Mark Zuckerberg - Barron's

The recent news and significant events suggest volatility in Meta's stock price.

**Analyst Opinions**
-------------------

Analyst Consensus:
- Key: Strong_Buy
- Mean (1=StrongBuy~5=Sell): 1.36 (~Strong Buy)
- Opinions: 59
- Target Price (avg/high/low): 835.59 / 1117.00 / 685.00

The analyst opinions are overwhelmingly positive.

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-30 | 1.08 | $51.24B |
| 2025-07-31 | 7.28 | $47.52B |
| 2025-05-01 | 6.59 | $42.31B |
| 2024-10-31 | 6.2 | $40.59B |
| 2025-10-30 | 6.2 | $40.59B |

The recent earnings analysis indicates steady revenue growth, but volatile EPS.

**Financial Information**
------------------------

Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $51.24B | 82.03% |
| 2025-06-30 | $47.52B | 82.13% |
| 2025-03-31 | $42.31B | 82.11% |
| 2024-12-31 | $48.38B | 81.73% |
| 2024-09-30 | $40.59B | 81.83% |

Capital and Profitability:

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $194.07B | 1.40% |
| 2025-06-30 | $195.07B | 9.40% |
| 2025-03-31 | $185.03B | 9.00% |
| 2024-12-31 | $182.64B | 11.41% |
| 2024-09-30 | $164.53B | 9.54% |

The financial information indicates steady revenue growth and consistent profit margins.

**Comprehensive Analysis**
---------------------------

Meta's stock has been volatile, with a cumulative return of 95.78% and a divergence of 2.48% compared to the S&P 500. The RSI and PPO indicators suggest a bearish trend, while the MRI and Expected Return indicate a medium-risk investment. The recent earnings analysis indicates steady revenue growth, but volatile EPS. The analyst opinions are overwhelmingly positive, with a mean rating of 1.36 (~Strong Buy) and a target price of $835.59.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.